Autologous Platelet-Rich Plasma for Diabetic Foot Ulcer.
Shiying Shao, Ruping Pan, Yong Chen
https://pubmed.ncbi.nlm.nih.gov/33199085/Actively Recruiting
Led by University of the Punjab · Updated on 2024-12-31
28
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating the use of autologous adipose tissue-derived cells combined with platelet rich plasma PRP to treat chronic diabetic foot ulcers. This study aims to compare the therapeutic effectiveness of uncultured stromal vascular fraction SVF cells and cultured adipose derived stem cells ASCs, both supplemented with PRP, which contains factors that support cell survival and wound healing. The study focuses on patients with diabetic neuropathy and chronic foot ulcers, seeking to identify the more effective treatment option while ensuring safety through the use of the patients own cells. Under local or general anesthesia, fat tissue is collected from the patient using manual aspiration. SVF and ASCs are isolated from this tissue through enzymatic digestion, then assessed for quality and cell type before use. PRP is prepared from the patients blood on the day of treatment. Four study groups receive different interventions standard wound care with saline dressings PRP injections alone PRP mixed with SVF cells and PRP mixed with cultured ASCs. The cell and PRP mixture is injected intradermally at the wound border and surface, with dosage based on wound size. Participants will be monitored for three months, with regular interviews and visual checks to assess ulcer healing. The primary outcome is the rate of ulcer recovery, while secondary measures include the percentage of wound closure over time. The study includes assessments like cell quality testing, wound inspections, and patient interviews to track progress. Safety and treatment effects are observed throughout the study period, which lasts up to three months after treatment.
CONDITIONS
Efficacy of Adipose Tissue Derived Stem Cells for the Treatment of Diabetic Foot Ulcers
A
Azra Mehmood, PhD
A
Amna Arif, M.Phil.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of the Punjab
Lead Sponsor
Centre of Excellence in Molecular Biology, University of the Punjab, Lahore
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Single treatment session with follow-up over 3 months
Participants receive injections of PRP alone, PRP with stromal vascular fraction (SVF), PRP with cultured adipose derived stem cells (ASCs), or standard wound care management at the wound site under local or general anesthesia.
1 injection visit and multiple follow-up visits over 3 months
Duration - 3 months
Participants are monitored for wound healing and ulcer recovery through interviews and visual inspections over 3 months after treatment.
Multiple follow-up visits over 3 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Shiying Shao, Ruping Pan, Yong Chen
https://pubmed.ncbi.nlm.nih.gov/33199085/Francisco Javier Álvaro-Afonso, Irene Sanz-Corbalán, José Luis Lázaro-Martínez...
https://pubmed.ncbi.nlm.nih.gov/32723090/Shilu Yin, Xin Yang, Hongsen Bi...
https://pubmed.ncbi.nlm.nih.gov/32131655/Triantafyllos Didangelos, George Koliakos, Kokkona Kouzi...
https://pubmed.ncbi.nlm.nih.gov/29715071/Amanullah Khan, Nabeea Junaid
https://pubmed.ncbi.nlm.nih.gov/29256523/Grant Switzer Nolan, Oliver John Smith, Susan Heavey...
https://pubmed.ncbi.nlm.nih.gov/34169656/H L Qin, X H Zhu, B Zhang...
https://pubmed.ncbi.nlm.nih.gov/27219884/Michael H Carstens, Francisco J Quintana, Santos T Calderwood...
https://pubmed.ncbi.nlm.nih.gov/33826245/Seung-Kyu Han, Hong-Ryul Kim, Woo-Kyung Kim
https://pubmed.ncbi.nlm.nih.gov/20492632/University of the Punjab
Lead Sponsor
Centre of Excellence in Molecular Biology, University of the Punjab, Lahore
Collaborating Sponsor